Näytetään 23 541 - 23 560 yhteensä 23 673 tuloksesta haulle '"cancer"', hakuaika: 0,14s Tarkenna hakua
  1. 23541

    Robot-assisted endoscopic submucosal dissection is effective in treating patients with early-stage gastric neoplasia Tekijä Phee, Soo Jay, Reddy, Nageshwar, Chiu, Philip W. Y., Rebala, Pradeep, Rao, Guduru V., Wang, Zheng, Sun, Zhenglong, Wong, Jennie Y. Y., Ho, Khek–Yu

    Julkaistu 2013
    “…Background & Aims Endoscopic submucosal dissection (ESD) is a new technique for endoscopic resection of early-stage gastrointestinal cancers. Though ESD achieves high rate of en bloc resection, it is technically difficult to master. …”
    Hae kokoteksti
    Hae kokoteksti
    Journal Article
  2. 23542

    ANALISIS BIAYA TERAPI STROKE HEMORAGI PADA PASIEN RAWAT INAP DI RS PKU MUHAMMADIYAH YOGYAKARTA NOVEMBER 2011-2013 Tekijä , Niken Feladita, , Dr. Satibi, M.Si, Apt.

    Julkaistu 2014
    “…Stroke is the third death factors in the US after heart disease and cancers. It is suggested that the cost for dealing with stroke will be doubled in. …”
    Opinnäyte
  3. 23543

    Identification of potential targets of the curcumin analog CCA‑1.1 for glioblastoma treatment: integrated computational analysis and in vitro study Tekijä Hermawan, Adam, Wulandari, Febri, Hanif, Naufa, Utomo, Rohmad Yudi, Jenie, Riris Istighfari, Ikawati, Muthi', Tafrihani, Ahmad Syauqy

    Julkaistu 2022
    “…Curcumin has anticancer activity against aggressive cancers, such as leukemia, and GBM; however, its application is limited by its low solubility and bioavailability. …”
    Hae kokoteksti
    Artikkeli
  4. 23544

    Studying protein interaction and glycosylation with chemical proteomics Tekijä Nadal, S

    Julkaistu 2020
    “…</p> <p>The second chapter demonstrates de novo determination of the sequence and protein N-glycosylation of the anti- H2AX monoclonal antibody, enabling structural modelling of the antigen recognition and laying the groundwork for further development of this diagnostic reagent for DNA damage in cancers. Chapter 3 focusses on improving analysis of protein O-glycosylation using tandem mass spectrometry. …”
    Opinnäyte
  5. 23545

    Discovery of small molecule epigenetic modulators Tekijä Moustakim, M

    Julkaistu 2018
    “…Up to this date there have been no reported inhibitors or chemical probes for the YEATS domain containing proteins despite numerous links to cancers.</p> <p>The final chapter 5 describes the outputs from the industrial placement period of my doctoral training during which synthetic methodology and total synthesis research at Vertex Pharmaceuticals was carried out. …”
    Opinnäyte
  6. 23546

    Melanomas in renal transplant recipients. Tekijä Le Mire, L, Hollowood, K, Gray, D, Bordea, C, Wojnarowska, F

    Julkaistu 2006
    “…BACKGROUND: It is well documented that renal transplant recipients are at increased risk of developing skin cancers, in particular squamous cell carcinomas. Less extensively reviewed in the literature is the increased incidence of malignant melanoma. …”
    Journal article
  7. 23547

    Molecular characteristics of serrated adenomas of the colorectum. Tekijä Sawyer, E, Cerar, A, Hanby, A, Gorman, P, Arends, M, Talbot, I, Tomlinson, I

    Julkaistu 2002
    “…Molecular studies comparing SAs and classical adenomas suggest that each may be a distinct entity; in particular, it has been proposed that microsatellite instability (MSI) distinguishes SAs from classical adenomas and that SAs and the colorectal cancers arising from them develop along a pathway driven by low level microsatellite instability (MSI-L). …”
    Journal article
  8. 23548

    Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the most? Tekijä Ntentas, G, Dedeckova, K, Andrlik, M, Aznar, M, George, B, Kubeš, J, Darby, S, Cutter, D

    Julkaistu 2019
    “…<p><strong>Purpose</strong></p> <p>Radiation therapy (RT) improves control of Hodgkin lymphoma (HL), but patients who undergo RT are at risk for late effects, including cardiovascular disease and second cancers, because of radiation doses to organs at risk (OARs). …”
    Journal article
  9. 23549

    Benzodiazepines and related drugs for insomnia in palliative care. Tekijä Hirst, A, Sloan, R

    Julkaistu 2002
    “…SELECTION CRITERIA: Studies considered for inclusion were randomized controlled trials of adult patients in any setting, receiving palliative care or suffering an incurable progressive medical condition. (For example, cancers, AIDS, Motor Neurone Disease, Multiple Sclerosis, Parkinson's Disease, Chronic Obstructive Pulmonary Disease). …”
    Journal article
  10. 23550

    Associations of circulating insulin-like growth factor-I with intake of dietary proteins and other macronutrients Tekijä Watling, C, Kelly, R, Tong, Y, Piernas, C, Watts, E, Tin Tin, S, Knuppel, A, Schmidt, J, Wrightson, R, Key, T, Travis, R

    Julkaistu 2021
    “…<p><strong>Background:</strong> Circulating insulin-like growth factor-I (IGF-I) is associated with the risk of several cancers. Dietary protein intake, particularly dairy protein, may increase circulating IGF-I; however, associations with different protein sources, other macronutrients, and fibre are inconclusive.…”
    Journal article
  11. 23551

    Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy Tekijä Wedlake, L, Shaw, C, McNair, H, Lalji, A, Mohammed, K, Klopper, T, Allan, L, Tait, D, Hawkins, M, Somaiah, N, Lalondrelle, S, Taylor, A, VanAs, N, Stewart, A, Essapen, S, Gage, H, Whelan, K, Andreyev, H

    Julkaistu 2017
    “…Background: Therapeutic radiotherapy is an important treatment of pelvic cancers. Historically, low-fiber diets have been recommended despite a lack of evidence and potentially beneficial mechanisms of fiber.Objective: This randomized controlled trial compared low-, habitual-, and high-fiber diets for the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapy.Design: Patients were randomly assigned to low-fiber [≤10 g nonstarch polysaccharide (NSP)/d], habitual-fiber (control), or high-fiber (≥18 g NSP/d) diets and received individualized counseling at the start of radiotherapy to achieve these targets. …”
    Journal article
  12. 23552

    Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication. Tekijä Farquhar, M, Humphreys, I, Rudge, S, Wilson, G, Bhattacharya, B, Ciaccia, M, Hu, K, Zhang, Q, Mailly, L, Reynolds, G, Aschcroft, M, Balfe, P, Baumert, T, Roessler, S, Wakelam, M, McKeating, J

    Julkaistu 2017
    “…Autotaxin generates the biologically active lipid lysophosphatidic acid that has been reported to play a tumorigenic role in a wide number of cancers. In this study we show that Hepatitis C virus infection increases autotaxin expression via hypoxia inducible transcription factor and provides an environment in the liver that promotes fibrosis and liver injury. …”
    Journal article
  13. 23553

    Understanding drug resistance through computational models of the genotype-phenotype mapping Tekijä Nichol, D

    Julkaistu 2018
    “…If we are to predict or reverse evolution, as we must to determine effective treatments for drug-resistant infections and cancers, then we must first understand the relationship between genetic and phenotypic change. …”
    Opinnäyte
  14. 23554

    MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Tekijä Chi, J, Ballabio, E, Chen, X, Kušec, R, Taylor, S, Hay, D, Tramonti, D, Saunders, N, Littlewood, T, Pezzella, F, Boultwood, J, Wainscoat, J, Hatton, C, Lawrie, C

    Julkaistu 2011
    “… BACKGROUND: MicroRNAs are small RNA species that regulate gene expression post-transcriptionally and are aberrantly expressed in many cancers including hematological malignancies. However, the role of microRNAs in the pathogenesis of multiple myeloma (MM) is only poorly understood. …”
    Journal article
  15. 23555

    Design and synthesis of myo-inositol (1,4,5)-trisphosphate receptor antagonists Tekijä Ye, Y

    Julkaistu 2013
    “…Hence, selective blockage of Ins<em>P<sub>3</sub> </em>Rs will allow better understanding of Ca<sup>2+</sup> signalling and might also unveil novel treatment for cancers, in the long term. There were no selective Ins<em>P<sub>3</sub> </em>Rs antagonists known at the start of these studies. …”
    Opinnäyte
  16. 23556

    Synthesis of deuterated phosphatidylinositol phosphates Tekijä Saunders, A

    Julkaistu 2016
    “…Dysfunction of these processes has been implicated in numerous diseases including diabetes and many cancers. Some aspects of PtdInsP<sub>n</sub> signalling have been heavily investigated; PTEN, PKC/Akt, PtdIns3K and PtdIns4K are all important therapeutic targets that have seen much attention in industrial endeavours. …”
    Opinnäyte
  17. 23557

    Radionuclide imaging of angiogenesis Tekijä Patel, N

    Julkaistu 2013
    “…<p>Angiogenesis is a fundamental process in the survival, growth and spread of cancers. In recent years several therapies have been developed to interfere with this process. …”
    Opinnäyte
  18. 23558

    Presentation of B-cell lymphoma in childhood and adolescence: a systematic review and meta-analysis Tekijä Saatci, D, Zhu, C, Harnden, A, Hippisley-Cox, J

    Julkaistu 2024
    “…Background: The diagnosis of B-cell lymphoma, one of the commonest cancers seen in childhood and adolescence, is challenging. …”
    Journal article
  19. 23559

    Unravelling the molecular and cellular mechanisms of fetal B cell lymphopoiesis to help understand childhood leukaemia Tekijä Green, J

    Julkaistu 2015
    “…<p>Childhood Leukaemia accounts for nearly one in three of all childhood cancers, with approximately 400 cases diagnosed in the UK every year. …”
    Opinnäyte
  20. 23560

    Biosynthesis and characterization of silver nanoparticles from Cedrela toona leaf extracts: An exploration into their antibacterial, anticancer, and antioxidant potential Tekijä Javed, MA, Ali, B, Sarfraz, MH, Ali, S, Liaqat, E, Afzal, MS, Wang, Y, Peng, L, ur Rehman, A, Aftab, MN, Alarjani, KM, Elshikh, MS

    Julkaistu 2024
    “…The crux of this research is that AgNPs synthesized from the Cedrela toona leaf extract could be employed as antibacterial, antioxidant, and anticancer agents for the treatment of bacterial, free radical-oriented, and cancerous diseases.…”
    Journal article